Tiagabine-induced non-convulsive status epilepticus in a patient without history of epilepsy

Neurosciences

Volumn 12, Issue 2, 2007, Pages 152-154

  Haddad, Naim I ^a   Umashankar, Gopalan ^a   Harik, Sami I ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; GEMFIBROZIL; GLIBENCLAMIDE; LISINOPRIL; LORAZEPAM; OLANZAPINE; TIAGABINE;

ADULT; ANAMNESIS; ARTICLE; BRAIN RADIOGRAPHY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HUMAN; LABORATORY TEST; MALE; MENTAL HEALTH; MOOD DISORDER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOID SCHIZOPHRENIA; PHYSICAL EXAMINATION; SLOW BRAIN WAVE;

EID: 34247208115     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Knake S, Hamer HM, Schomburg U, Oertel WH, Rosenow F. Tiagabine induced absence status in idiopathic generalized epilepsy. Seizure 1999; 8: 314-317.
2. Ettinger AB, Bernal OG, Andriola MR, Bagshi S, Flores P, Just C, et al. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 1999; 40: 1159-1162.
3. Fitzek S, Hegemann S, Sauner D, Bonsch D, Fitzek C. Drug induced non convulsive status epilepticus with low dose tiagabine. Epileptic Disord 2001; 3: 147-150.
4. Kellinghaus C, Dziewas R, Ludermann P. Tiagabine related non convulsive status epilepticus in partial epilepsy: three case reports and a review of literature. Seizure 2002; 11: 243-249.
5. Skardoutsou A, Voudris KA, Vagiakou EA. Non convulsive status epilepticus associated with tiagabine therapy in children. Seizure 2003; 12: 599-601.
6. Shinnar S, Berg AT, Treiman DM, Hauser WA, Hersdorffer DC, Sackellares JC, et al. Status Epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Epilepsia 2001; 42: 372-379.
7. Bauer J, Bergmann A, Reuber M, Stodieck SRG, Genton P. Tolerability of tiagabine: a prospective open label study. Epileptic Disord 2002; 4: 257-260.
8. Hosford DA, Wang Y. Utility of lethargic (lh/lh) mouse model of absence seizures in predicting effects of lamotrigine, vigabatrin, tiagabine, gabapentin and topiramate against human absence seizures. Epilepsia 1997; 38: 408-414.
9. Coenen AM, Blezer EH, Van Luijtelaar EL. Effects of GABA uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behavior of rats. Epilepsy Res 1995; 21: 89-94.
10. Brenner RP. Is it Status? Epilepsia 2002; 43 (Suppl 3): 103-113.
11. Silvestri RC, Bromfield EB, Khosbin S. Clozapine induced seizures and EEG abnormalities in ambulatory psychiatry patients. Ann Pharmacother 1998; 32: 1147-1151.
12. Wyderski RJ, Starrett WG, Abou-Saif A. Fatal status epilepticus associated with olanzapine therapy. Ann Pharmacother 1999; 33: 787-789.
13. Leach JP, Brodie MJ. Tiagabine. Lancet 1998: 351: 203-207.
14. Jackson MF, Esplin B, Capek R. Activity-dependent enhancement of hyperpolarizing and depolarizing GABA synaptic responses following inhibition of GABA uptake by tiagabine. Epilepsy Res 1999; 37: 25-36.
15. Walton NY, Gunawan S, Treiman DM. Treatment of experimental status epilepticus with GABA inhibitor, tiagabine. Epilepsy Res 1994; 19: 237-244.